Literature DB >> 23190329

Preoperative masked renal damage in Japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy.

Takanobu Utsumi1, Koji Kawamura, Takashi Imamoto, Hidekazu Nagano, Tomoaki Tanaka, Naoto Kamiya, Naoki Nihei, Yukio Naya, Hiroyoshi Suzuki, Tomohiko Ichikawa.   

Abstract

OBJECTIVE: Correct interpretation of renal function in patients with primary aldosteronism is difficult before adrenalectomy, because subtle kidney impairment is often masked by glomerular hyperfiltration peculiar to primary aldosteronism. The aim of this study was to investigate postoperative changes in renal function for patients with primary aldosteronism and to identify clinical predictors of chronic kidney disease manifested postoperatively in the patients without pre-existing chronic kidney disease.
METHODS: Records of 78 Japanese patients who underwent unilateral adrenalectomy for primary aldosteronism were retrospectively surveyed. Patients who had been followed up for <6 months were excluded. Preoperative and postoperative estimated glomerular filtration rate were compared. Furthermore, uni- and multivariate analyses were carried out to identify clinical predictors for chronic kidney disease manifested postoperatively.
RESULTS: Patients with preoperative estimated glomerular filtration rate ≥60 mL/min/1.73 m(2) showed a significant decrease after surgery. Of the 66 patients without pre-existing chronic kidney disease, 24 developed chronic kidney disease postoperatively. Multivariate logistic regression analysis identified a medical history of dyslipidemia as an independent predictor for chronic kidney disease manifested postoperatively. According to univariate analyses, additional factors associated with postoperative manifestation of chronic kidney disease included older age, lower diastolic blood pressure and lower estimated glomerular filtration rate.
CONCLUSIONS: The interpretation of normal or abnormal renal functions by examining estimated glomerular filtration rate heightened by hyperfiltration alone can mislead clinicians before adrenalectomy. Clinicians should pay attention to patients at greater risk of a significant decline in postoperative renal function.
© 2012 The Japanese Urological Association.

Entities:  

Keywords:  Japanese; adrenalectomy; chronic kidney disease; primary aldosteronism; renal damage

Mesh:

Year:  2012        PMID: 23190329     DOI: 10.1111/iju.12029

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  14 in total

1.  Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism.

Authors:  Takanobu Utsumi; Naoto Kamiya; Mayuko Kaga; Takumi Endo; Masashi Yano; Shuichi Kamijima; Koji Kawamura; Takashi Imamoto; Tomohiko Ichikawa; Hiroyoshi Suzuki
Journal:  World J Urol       Date:  2017-04-11       Impact factor: 4.226

2.  Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function.

Authors:  Il Young Kim; In Seong Park; Min Jeong Kim; Miyeun Han; Harin Rhee; Eun Young Seong; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak; Sang Heon Song; Hyun Chul Chung
Journal:  Int Urol Nephrol       Date:  2018-05-19       Impact factor: 2.370

3.  Risk of New-Onset Dyslipidemia After Laparoscopic Adrenalectomy in Patients with Primary Aldosteronism.

Authors:  Mayuko Kaga; Takanobu Utsumi; Tomoaki Tanaka; Takashi Kono; Hidekazu Nagano; Koji Kawamura; Naoto Kamiya; Takashi Imamoto; Naoki Nihei; Yukio Naya; Hiroyoshi Suzuki; Tomohiko Ichikawa
Journal:  World J Surg       Date:  2015-12       Impact factor: 3.352

4.  Hypertension Cure Following Laparoscopic Adrenalectomy for Hyperaldosteronism is not Universal: Trends Over Two Decades.

Authors:  Takeshi Namekawa; Takanobu Utsumi; Tomoaki Tanaka; Mayuko Kaga; Hidekazu Nagano; Takashi Kono; Koji Kawamura; Naoto Kamiya; Takashi Imamoto; Hiroyoshi Suzuki; Tomohiko Ichikawa
Journal:  World J Surg       Date:  2017-04       Impact factor: 3.352

5.  Kidney dysfunction following adrenalectomy in autosomal dominant polycystic kidney disease complicated with primary aldosteronism: A case report.

Authors:  Hiroyuki Hirai; Makoto Kanno; Tsuyoshi Watanabe; Hiroaki Satoh
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

6.  Editorial comment from Dr Nishikawa et al. to preoperative masked renal damage in japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy.

Authors:  Tetsuo Nishikawa; Masao Omura; Jun Saito; Yoko Matsuzawa; Tomoshige Kino
Journal:  Int J Urol       Date:  2012-12-11       Impact factor: 3.369

7.  [Chronic kidney disease after adrenalectomy in a patient with primary aldosteronism].

Authors:  W C An; H X Yan; Z Z Deng; F Chen; X H Ou; H X Jin; W Huang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

8.  Transtubular potassium gradient predicts kidney function impairment after adrenalectomy in primary aldosteronism.

Authors:  Hung-Wei Liao; Shuo-Meng Wang; Chieh-Kai Chan; Yen-Hung Lin; Po-Chih Lin; Chen-Hsun Ho; Yu-Chun Liu; Jeff S Chueh; Vin-Cent Wu
Journal:  Ther Adv Chronic Dis       Date:  2020-08-27       Impact factor: 5.091

9.  Development of a novel nomogram to predict hypertension cure after laparoscopic adrenalectomy in patients with primary aldosteronism.

Authors:  Takanobu Utsumi; Naoto Kamiya; Takumi Endo; Masashi Yano; Shuichi Kamijima; Koji Kawamura; Takashi Imamoto; Yukio Naya; Tomohiko Ichikawa; Hiroyoshi Suzuki
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

10.  Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism.

Authors:  Do Hee Kim; Hee Jin Kwon; Sang A Ji; Hye Ryoun Jang; Sin-Ho Jung; Jung-Han Kim; Jae Hyeon Kim; Jung Eun Lee; Wooseong Huh; Yoon-Goo Kim; Dae Joong Kim; Ha Young Oh
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.